IRIS Accounts Production v23.4.0.336 05277050 Board of Directors 1.12.22 30.11.23 30.11.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh052770502022-11-30052770502023-11-30052770502022-12-012023-11-30052770502021-11-30052770502021-12-012022-11-30052770502022-11-3005277050ns15:EnglandWales2022-12-012023-11-3005277050ns14:PoundSterling2022-12-012023-11-3005277050ns10:Director12022-12-012023-11-3005277050ns10:PrivateLimitedCompanyLtd2022-12-012023-11-3005277050ns10:SmallEntities2022-12-012023-11-3005277050ns10:AuditExempt-NoAccountantsReport2022-12-012023-11-3005277050ns10:SmallCompaniesRegimeForDirectorsReport2022-12-012023-11-3005277050ns10:SmallCompaniesRegimeForAccounts2022-12-012023-11-3005277050ns10:FullAccounts2022-12-012023-11-3005277050ns10:Director22022-12-012023-11-3005277050ns10:RegisteredOffice2022-12-012023-11-3005277050ns5:CurrentFinancialInstruments2023-11-3005277050ns5:CurrentFinancialInstruments2022-11-3005277050ns5:Non-currentFinancialInstruments2023-11-3005277050ns5:Non-currentFinancialInstruments2022-11-3005277050ns5:ShareCapital2023-11-3005277050ns5:ShareCapital2022-11-3005277050ns5:RetainedEarningsAccumulatedLosses2023-11-3005277050ns5:RetainedEarningsAccumulatedLosses2022-11-3005277050ns5:PlantMachinery2022-12-012023-11-3005277050ns5:PlantMachinery2022-11-3005277050ns5:PlantMachinery2023-11-3005277050ns5:PlantMachinery2022-11-3005277050ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-11-3005277050ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-11-3005277050ns5:RetainedEarningsAccumulatedLosses2022-11-3005277050ns5:RetainedEarningsAccumulatedLosses2022-12-012023-11-30
REGISTERED NUMBER: 05277050 (England and Wales)















FOREVER YOUNG MEDICAL AESTHETICS LIMITED

Unaudited Financial Statements for the Year Ended 30 November 2023






FOREVER YOUNG MEDICAL AESTHETICS LIMITED (REGISTERED NUMBER: 05277050)






Contents of the Financial Statements
for the year ended 30 November 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


FOREVER YOUNG MEDICAL AESTHETICS LIMITED

Company Information
for the year ended 30 November 2023







DIRECTORS: M Barnes
Dr P N Steventon





REGISTERED OFFICE: Nightingale House
46-48 East Street
Epsom
Surrey
KT17 1HQ





REGISTERED NUMBER: 05277050 (England and Wales)





ACCOUNTANTS: Tudor John Limited
Nightingale House
46-48 East Street
Epsom
Surrey
KT17 1HQ

FOREVER YOUNG MEDICAL AESTHETICS LIMITED (REGISTERED NUMBER: 05277050)

Balance Sheet
30 November 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 262,038 306,561

CURRENT ASSETS
Stocks 39,304 41,816
Debtors 5 68,571 45,909
Cash at bank 403 26,212
108,278 113,937
CREDITORS
Amounts falling due within one year 6 116,701 87,909
NET CURRENT (LIABILITIES)/ASSETS (8,423 ) 26,028
TOTAL ASSETS LESS CURRENT
LIABILITIES

253,615

332,589

CREDITORS
Amounts falling due after more than one
year

7

170,530

219,343
NET ASSETS 83,085 113,246

CAPITAL AND RESERVES
Called up share capital 775 775
Retained earnings 8 82,310 112,471
83,085 113,246

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

FOREVER YOUNG MEDICAL AESTHETICS LIMITED (REGISTERED NUMBER: 05277050)

Balance Sheet - continued
30 November 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 28 March 2024 and were signed on its behalf by:





M Barnes - Director


FOREVER YOUNG MEDICAL AESTHETICS LIMITED (REGISTERED NUMBER: 05277050)

Notes to the Financial Statements
for the year ended 30 November 2023

1. STATUTORY INFORMATION

Forever Young Medical Aesthetics Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements have been prepared on the going concern basis.

The financial statements are presented in Sterling which is the functional currency of the company.

TURNOVER
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

TANGIBLE FIXED ASSETS
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance

STOCKS
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

FINANCIAL INSTRUMENTS
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments.

TAXATION
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

DEFERRED TAX
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

HIRE PURCHASE AND LEASING COMMITMENTS
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

FOREVER YOUNG MEDICAL AESTHETICS LIMITED (REGISTERED NUMBER: 05277050)

Notes to the Financial Statements - continued
for the year ended 30 November 2023

2. ACCOUNTING POLICIES - continued

PENSION COSTS AND OTHER POST-RETIREMENT BENEFITS
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 18 (2022 - 20 ) .

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 December 2022
and 30 November 2023 562,377
DEPRECIATION
At 1 December 2022 255,816
Charge for year 44,523
At 30 November 2023 300,339
NET BOOK VALUE
At 30 November 2023 262,038
At 30 November 2022 306,561

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 1,000 -
Other debtors 67,571 45,909
68,571 45,909

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Bank loans and overdrafts 65,295 46,233
Trade creditors 26,607 20,946
Taxation and social security 20,008 15,640
Other creditors 4,791 5,090
116,701 87,909

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2023 2022
£    £   
Bank loans 170,530 219,343

FOREVER YOUNG MEDICAL AESTHETICS LIMITED (REGISTERED NUMBER: 05277050)

Notes to the Financial Statements - continued
for the year ended 30 November 2023

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR - continued
2023 2022
£    £   
Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal 118,952 170,530

8. RESERVES
Retained
earnings
£   

At 1 December 2022 112,471
Deficit for the year (30,161 )
At 30 November 2023 82,310

9. RELATED PARTY DISCLOSURES

During the year ended 30th November 2023, consultancy fees totalling £20,000 (2022: £17,500) were paid to A Young, a related party to the directors of the company.